← European Medicine Shortage Tracker · all medicines

Fulvestrant shortage — availability across Europe

Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.

MEDICALLY REVIEWED
Dr. Chrysoula I. Liakou MD, PhD
Internal Medicine Specialist
Cancer Immunology Researcher
Reviewed 30 July 2026 · next review due 30 January 2027

Fulvestrant currently has availability issues reported in 3 European registers: Spain, Greece, Italy.

Shortage  ATC L02BA03 · also listed as: FULVESTRANT · data refreshed 5 September 2026

Key facts

As of 5 September 2026, 3 of the 9 tracked registers list current availability issues for Fulvestrant, covering 6 affected product presentations. The longest-running open report was filed in Spain on 2025-05-13 and has now been open for about 16 months. Where agencies state a cause, commercial decisions or discontinuation lead with 2 of the 5 stated-cause reports, followed by delivery delays with 1. The furthest expected-resolution date currently on file is 2026-11-29; the earliest is 2026-09-05. The issue spread across registers over time rather than at once: Spain reported first (2025-05-13), with Greece following roughly 12 months later — a pattern typical of supply problems cascading between national markets. Registers in Spain, Italy indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Fulvestrant is coded L02BA03 — a medicine acting on antineoplastic and immunomodulating agents — so clinically related products appear under “Related medicines” below.

WhereStatus & productsSinceExpected end Reason / alternativesSource
🇪🇸 SpainShortage
FULVESTRANT EUGIA 250 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA EFG, 1 jeringa + 1 aguja
2025-05-132026-11-29Existen otros medicamentos con el mismo principio activo y misma vía.
Alternatives: Existe/n otro/s medicamento/s con el mismo principio activo y para la misma vía de administración.
register ↗
🇬🇷 GreeceLimited availability
SYR x5 ml + 2 βελόνες ασφαλείας
2026-05-292026-09-05Καθυστέρηση παράδοσης περιεκτικότητας Εναλλακτικά άλλα σκευάσματα τηςregister ↗
🇮🇹 ItalyShortage
FULVESTRANT ACCORD
+ 3 more products
FULVESTRANT DR. REDDY'S
FULVESTRANT MYLAN
FULVESTRANT ZENTIVA
2025-08-30Motivi commerciali
Alternatives: AIFA: equivalents with the same active substance are available.
register ↗

New register reports per month

2025-05: 12025-06: 02025-07: 02025-08: 12025-09: 02025-10: 02025-11: 02025-12: 02026-01: 02026-02: 02026-03: 02026-04: 02026-05: 32025-052026-05

Full report history (6 register entries)

Every individual register entry for Fulvestrant in the tracked sources, newest first — including resolved and discontinued reports.

Reg.ProductStatusReportedExpected endStated reason
🇮🇹 ITFULVESTRANT DR. REDDY'SShortage2026-10-02Elevata richiesta: forniture discontinue
🇮🇹 ITFULVESTRANT ACCORDShortage2026-05-31Motivi commerciali
🇬🇷 GRSYR x5 ml + 2 βελόνες ασφαλείαςLimited availability2026-05-292026-09-05Καθυστέρηση παράδοσης περιεκτικότητας Εναλλακτικά άλλα σκευά
🇮🇹 ITFULVESTRANT MYLANShortage2026-05-01Cessata commercializzazione definitiva
🇮🇹 ITFULVESTRANT ZENTIVAShortage2025-08-30Problemi produttivi
🇪🇸 ESFULVESTRANT EUGIA 250 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA EFGShortage2025-05-132026-11-29Existen otros medicamentos con el mismo principio activo y m

Frequently asked

Is Fulvestrant currently in shortage in Europe?

Yes. As of 5 September 2026, availability issues are reported in: Spain, Greece, Italy. Availability is national — a shortage in one country does not mean it is short everywhere.

When is the Fulvestrant shortage expected to end?

Agency prognoses on file range from 2026-09-05 to 2026-11-29. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.

Are there alternatives to Fulvestrant?

5 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.

Where does this Fulvestrant availability data come from?

Directly from the official medicines-agency registers that list Fulvestrant: AEMPS CIMA (Spain), EOF limited-availability list (Greece), AIFA (Italy). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Related medicines (same ATC class)

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Fulvestrant — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/fulvestrant/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Fulvestrant availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/fulvestrant/">Fulvestrant shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>
Cite: “Fulvestrant: availability status across 3 European registers — European Medicine Shortage Tracker (MobiDoctor), 5 September 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.